Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06510062 · ClinicalTrials.gov registry record · Phase 1
Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
A Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body, sponsored by ZetrOZ.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT06510062 is a Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body that has completed, run by ZetrOZ. The registered enrollment target is 67 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06510062, a Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
Conditions Studied
Interventions
- DRUG 2.5% Diclofenac Patches
- DEVICE Sustained Acoustic Medicine
Study Locations (1)
Connecticut
- ZetrOZ Systems LLC - Trumbull
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-07-22 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06510062
The ClinicalTrials.gov registry entry for NCT06510062 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Measurement of Circulation on Anatomical Locations of the Body appearing as the primary indexed condition, and to 2 interventions - of which 2.5% Diclofenac Patches is the first listed.
NCT06510062 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06510062 about?
NCT06510062 is a clinical study titled "Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation". Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
What is the current status of trial NCT06510062?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2024-07-22. Estimated completion is 2024-12-31.
What conditions does trial NCT06510062 study?
This clinical trial studies the following conditions: Measurement of Circulation on Anatomical Locations of the Body.
What interventions are being tested in trial NCT06510062?
The interventions under investigation include: 2.5% Diclofenac Patches (DRUG), Sustained Acoustic Medicine (DEVICE).
Who is sponsoring clinical trial NCT06510062?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06510062 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.